Integer Holdings Corp (ITGR) Was Down 40% YOY Despite Strong Market Position and a Competitive Moat

Core Insights - The 13D Activist Fund focuses on companies targeted by shareholder activists and reported a Q4 2025 return of 0.40%, underperforming the Russell 2000 Index which returned 2.19% [1] - Year-to-date, the Fund's return was 3.06% compared to the Index's 12.81% [1] - Despite challenges in beating market-weighted indexes, shareholder activism is on the rise [1] Company Overview: Integer Holdings Corporation - Integer Holdings Corporation (NYSE:ITGR) is a medical device contract development and manufacturing company with a market capitalization of $2.893 billion [2] - The stock closed at $85.23 per share on March 05, 2026, with a one-month return of -3.99% and a 52-week loss of 31.94% [2] - Integer is the largest publicly traded pure play medical device CDMO, specializing in cardiovascular and neuromodulation applications [3] Market Position and Challenges - Integer acts as an outsourced design and development partner for OEMs like Medtronic, Boston Scientific, and J&J, which creates a competitive moat due to high regulatory barriers [3] - Despite its strong market position, Integer's share price has declined over 40% year-to-date [3]